サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564990

血栓管理装置の世界市場

Clot Management Devices

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血栓管理装置の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血栓管理装置の世界市場は2030年までに29億米ドルに達する見込み

2023年に21億米ドルと推定された血栓管理装置の世界市場は、分析期間2023-2030年にCAGR 4.6%で成長し、2030年には29億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経皮的血栓除去装置は、CAGR 4.8％を記録し、分析期間終了までに11億米ドルに達すると予測されます。カテーテル直接血栓溶解療法（CDT）機器セグメントの成長率は、分析期間中CAGR 4.0％と推定されます。

米国市場は5億7,990万米ドル、中国はCAGR4.4％で成長予測

米国の血栓管理装置市場は、2023年に5億7,990万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4億6,340万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と3.8%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の血栓管理装置市場- 主要動向と促進要因のまとめ

なぜ血栓管理装置は現代医療において重要なツールになりつつあるのか？

血栓管理装置は、深部静脈血栓症（DVT）、肺塞栓症（PE）、虚血性脳卒中など、血栓の形成によって引き起こされる疾患の有病率の増加により、現代医療において大きな注目を集めています。これらの疾患は、心臓発作、脳卒中、慢性静脈不全といった生命を脅かす合併症を含め、深刻な健康リスクをもたらします。心血管疾患の増加、人口の高齢化、肥満や座りがちな生活などの生活習慣に関連する危険因子はすべて、血栓除去や管理のための介入を必要とする症例の急増に寄与しています。血栓を溶解・除去・予防するための血栓管理装置は、患者の予後を改善し、長期的な合併症のリスクを軽減するための重要な手段であると考えられています。低侵襲手術の出現により、これらのデバイスは、開腹手術や長期抗凝固療法といった従来の方法よりも、回復が早く、合併症が少なく、より的を絞った治療アプローチが可能なため、好ましい治療選択肢となっています。

技術の進歩は血栓管理ソリューションをどのように変えているか？

血栓管理デバイスの状況は、手技をより安全、迅速、効果的にする技術的進歩のおかげで急速に進化しています。最も重要な進歩のひとつは機械的血栓除去装置の分野であり、これは通常、低侵襲のカテーテルベースの処置中に、動脈や静脈から血栓を物理的に除去するように設計されています。これらの装置は、血栓を適時に除去することによって脳への血流を回復させ、永続的な損傷を防ぐことを可能にし、虚血性脳卒中の治療に革命をもたらしました。さらに、血栓溶解剤を血栓部位に直接投与するカテーテル直接血栓溶解療法は、精度と安全性の両面で改善が見られています。吸引して血栓を除去する吸引カテーテルや、血栓を小さく砕き、扱いやすくする回転血栓除去システムなどのデバイスは、DVTやPEの治療に臨床で利用されるようになってきています。さらに、生体吸収性の血栓回収装置やステントリトリーバーの開発により、長期合併症の少ない、より侵襲の少ない選択肢が提供されています。これらの進歩は、血栓管理装置の有効性を向上させるだけでなく、複雑でリスクの高い患者の治療に新たな道を開き、より広い医療現場でのこれらの技術の使用を拡大しています。

血栓管理装置はどこで最も大きなインパクトを与えていますか？

血栓管理装置は、様々な医療分野、特に循環器科、神経科、救急医療において、救命効果があることが証明されています。循環器内科では、血栓管理装置の使用は急性冠症候群や静脈血栓塞栓症（VTE）の治療に不可欠です。これらのデバイスは、血流を速やかに回復させ、心臓発作やその他の重篤な合併症につながる血栓の進行を防ぐのに役立ちます。神経学では、機械的血栓除去装置は、大血管の閉塞による虚血性脳卒中の治療のゴールドスタンダードと考えられています。重要な時間内に迅速に血栓を除去することで、神経学的転帰を大幅に改善し、長期的な障害のリスクを軽減することができます。救急医療では、血栓管理装置は生命を脅かす塞栓症や静脈閉塞に迅速に対処するために使用され、患者の回復を早め、集中治療リソースの全体的な負担を軽減します。また、がん患者、長期間動けない患者、遺伝的素因を持つ患者における血栓関連疾患の有病率の上昇により、集中治療室から外来診療所まで、より幅広いヘルスケア環境において、これらの機器の必要性が高まっています。医療関係者が血栓管理プロトコルを改良し続ける中、これらの機器は血栓性疾患患者の生存率と生活の質の向上に大きな影響を与えています。

血栓管理装置市場拡大の要因は？

血栓管理装置市場の成長は、心血管疾患、脳卒中、静脈血栓塞栓症の発生率の上昇など、いくつかの要因によって牽引されています。世界人口の高齢化は主要な要因であり、高齢者は血液循環の低下、併存疾患、長時間の不動などにより血栓のリスクが高くなります。さらに、肥満、座りがちな生活、喫煙などの生活習慣が、血栓管理の介入を必要とする病態の蔓延をさらに悪化させています。市場はまた、血栓除去手技をより安全、迅速、身近なものにした技術の進歩によっても後押しされています。ステントリトリーバーや吸引システムなどの機械的血栓除去装置の革新は、特に脳卒中管理における患者の転帰を劇的に改善しました。従来の手術に比べて回復時間が短縮され、合併症も少ない低侵襲手術の採用が拡大していることも、市場拡大の主な要因です。さらに、ヘルスケアプロバイダーが在院日数の短縮と長期的転帰の改善に注力する中、迅速かつ効果的な血栓除去が可能な機器への需要が高まっています。特に新興国市場における好意的な償還政策と、時宜を得た血栓介入の重要性に関する医師や患者の意識の高まりが、市場をさらに活性化しています。血栓関連疾患の発生率が上昇を続ける中、高度な血栓管理装置に対する需要は、こうした多様な要因によって大きく伸びると予想されます。

調査対象企業の例（注目の11社）

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11053

Global Clot Management Devices Market to Reach US$2.9 Billion by 2030

The global market for Clot Management Devices estimated at US$2.1 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Catheter-Directed Thrombolysis (CDT) Devices segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$579.9 Million While China is Forecast to Grow at 4.4% CAGR

The Clot Management Devices market in the U.S. is estimated at US$579.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$463.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Clot Management Devices Market - Key Trends and Drivers Summarized

Why Are Clot Management Devices Becoming a Critical Tool in Modern Medicine?

Clot management devices have gained significant attention in modern medicine due to the increasing prevalence of conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic strokes, which are all caused by the formation of blood clots. These conditions pose serious health risks, including life-threatening complications like heart attacks, strokes, and chronic venous insufficiency. The growing incidence of cardiovascular diseases, an aging population, and lifestyle-related risk factors such as obesity and sedentary behavior have all contributed to a surge in cases requiring intervention for blood clot removal or management. Clot management devices, designed to either dissolve, remove, or prevent blood clots, are seen as critical tools in improving patient outcomes and reducing the risk of long-term complications. With the advent of minimally invasive procedures, these devices have become a preferred treatment option over traditional methods like open surgery or long-term anticoagulant therapy, as they offer quicker recovery times, fewer complications, and more targeted treatment approaches.

How Are Technological Advancements Transforming Clot Management Solutions?

The clot management device landscape has evolved rapidly thanks to technological advancements that are making procedures safer, faster, and more effective. One of the most significant developments is in the area of mechanical thrombectomy devices, which are designed to physically remove clots from arteries or veins, typically during minimally invasive catheter-based procedures. These devices have revolutionized the treatment of ischemic strokes by allowing for timely removal of clots, thereby restoring blood flow to the brain and preventing permanent damage. Additionally, catheter-directed thrombolysis, where clot-dissolving agents are delivered directly to the site of the clot, has seen improvements in both precision and safety. Devices such as aspiration catheters, which use suction to remove clots, and rotational thrombectomy systems, which break clots into smaller, more manageable pieces, are increasingly being utilized in clinical practice to treat DVT and PE. Furthermore, the development of bioabsorbable clot retrieval devices and stent retrievers provides a less invasive option with fewer long-term complications. These advancements are not only improving the efficacy of clot management devices but are also opening new avenues for the treatment of complex and high-risk patients, expanding the use of these technologies in broader medical settings.

Where Are Clot Management Devices Making the Greatest Impact?

Clot management devices have proven to be life-saving in a variety of medical fields, particularly in cardiology, neurology, and emergency medicine. In cardiology, the use of clot management devices is critical in treating acute coronary syndromes and venous thromboembolism (VTE), which includes both DVT and PE. These devices help to quickly restore blood flow and prevent the progression of clots that can lead to heart attacks or other serious complications. In neurology, mechanical thrombectomy devices are now considered the gold standard for treating ischemic strokes caused by large vessel occlusions. Rapid clot removal within the crucial time window can significantly improve neurological outcomes and reduce the risk of long-term disability. In emergency medicine, clot management devices are used to quickly address life-threatening embolisms or venous blockages, allowing patients to recover more rapidly and reducing the overall strain on intensive care resources. The rising prevalence of clot-related conditions in patients with cancer, long-term immobility, or genetic predispositions has also increased the need for these devices across a broader range of healthcare settings, from intensive care units to outpatient clinics. As medical professionals continue to refine clot management protocols, these devices are making a profound impact on improving survival rates and quality of life for patients with thrombotic diseases.

What Factors are Driving the Expansion of the Clot Management Devices Market?

The growth in the clot management devices market is driven by several factors, including the rising incidence of cardiovascular diseases, strokes, and venous thromboembolism. An aging global population is a key contributor, as older individuals are at higher risk for blood clots due to slower circulation, comorbid conditions, and prolonged immobility. Additionally, lifestyle factors such as increasing rates of obesity, sedentary lifestyles, and smoking are further exacerbating the prevalence of conditions that require clot management intervention. The market is also propelled by technological advancements that have made clot removal procedures safer, quicker, and more accessible. Innovations in mechanical thrombectomy devices, such as stent retrievers and aspiration systems, have drastically improved patient outcomes, particularly in stroke management. The growing adoption of minimally invasive procedures, which offer reduced recovery times and fewer complications compared to traditional surgery, is another major driver of market expansion. Moreover, as healthcare providers focus on reducing hospital stays and improving long-term outcomes, there is increased demand for devices that can provide fast, effective clot resolution. Favorable reimbursement policies, particularly in developed healthcare markets, alongside rising awareness among physicians and patients about the importance of timely clot intervention, are further fueling the market. As the incidence of clot-related conditions continues to rise, the demand for advanced clot management devices is expected to grow significantly, driven by these diverse factors.

Select Competitors (Total 11 Featured) -

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Clot Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Propels Demand for Clot Management Devices
    • Increasing Incidence of Venous Thromboembolism (VTE) and Pulmonary Embolism (PE) Drives Market Growth
    • Advancements in Mechanical Thrombectomy Devices Strengthen the Business Case for Clot Removal Technologies
    • Expanding Use of Catheter-Directed Thrombolysis (CDT) Broadens the Addressable Market for Clot Management Solutions
    • Rising Adoption of Minimally Invasive Procedures Fuels Demand for Clot Management Devices
    • Increasing Focus on Stroke Prevention Throws the Spotlight on Effective Thrombectomy Devices
    • Growing Use of Clot Retrieval Devices in Emergency Rooms Accelerates Market Expansion
    • Development of Bioabsorbable Stents and Devices Expands Market Potential for Safer Clot Management
    • Rising Aging Population and Sedentary Lifestyles Sustain Demand for Clot Management Solutions
    • Increased Awareness of Stroke and Heart Attack Prevention Propels Market Growth for Prophylactic Clot Management Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clot Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION